MedPath

Contribution of Virtual Reality to the Well-being of Elderly Patients Hospitalized in SMR

Not Applicable
Not yet recruiting
Conditions
Virtual Reality
Registration Number
NCT06985732
Lead Sponsor
Centre Médical Porte Verte
Brief Summary

The objective of this clinical trial is to evaluate the effect of using virtual reality on the well-being of elderly patients hospitalized in SMR for 3 weeks. The study also allows to evaluate the effect of VR on apathy, and the autonomy of patients hospitalized in the SMR department for 3 weeks.

Detailed Description

Patients meeting the inclusion criteria and agreeing to participate in the study will be enrolled and then randomized to either the VR immersion group or the control group. Patients included in the protocol will not undergo any changes to their care. Patients in the experimental group will receive 12 virtual reality sessions in addition to their usual care.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

People hospitalized in the SMR unit at La Porte Verte Hospital for a minimum of 3 weeks,

  • People with preserved or slightly impaired cognitive status with an MMSE ≥ 20,
  • People who have been informed and have signed written informed consent
Exclusion Criteria

People under guardianship or curatorship,

  • People with difficulty understanding the VR study and materials,
  • People with vision problems that impact the use of VR,
  • People with hearing problems that impact the use of VR,
  • People with epilepsy,
  • People at risk of nausea and dizziness when using the VR headset,
  • People who cannot tolerate the VR headset,
  • Not affiliated with a social security scheme.
  • People receiving care with reflexology and relaxation massage

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
WHO-54 times throughout of study at baseline and after each VR session

measure well-being. The score is between 0-100 a high score means better wellness

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.